FDA Approves Globus Medical's Consolidated Imaging System

The FDA has approved Globus Medical Inc's (NYSE:GMED) Excelsius3D, an intelligent intraoperative 3-in-1 imaging system.
The imaging platform consolidates 360o cone-beam CT, fluoroscopy, and high-resolution digital radiography into one unified solution, eliminating the need for multiple imaging systems during one procedure.
The system offers omnidirectional wheels and the elimination of a separate viewing station.
Globus Medical is ramping up production and preparing for commercial release in Q4 of 2021.
Excelsius3D is a mobile X-ray system designed for 2D fluoroscopy, 2D digital radiography, and 3D imaging of adult and pediatric patients.
Price Action: GMED shares closed 2.04% higher at $77.96 on Monday.
Related content: Benzinga's Full FDA Calendar.